Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Fe.O.HO |
| Molecular Weight | 88.852 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[OH-].[O--].[Fe+3]
InChI
InChIKey=IEECXTSVVFWGSE-UHFFFAOYSA-M
InChI=1S/Fe.H2O.O/h;1H2;/q+3;;-2/p-1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/27995746 | http://onlinelibrary.wiley.com/doi/10.1002/047084289X.rn01568/abstract?userIsAuthenticated=false&deniedAccessCustomisedMessage=https://www.ncbi.nlm.nih.gov/pubmed/27684194 | https://www.ncbi.nlm.nih.gov/pubmed/17511797 | https://www.ncbi.nlm.nih.gov/pubmed/1427505https://books.google.ru/books?id=3hLmyma2-MsC&pg=PA241&lpg=PA241&dq=FERRIC+AMMONIUM+CHLORIDE retrieved from A Consumer's Dictionary of Cosmetic Ingredients, 7th Edition: Complete Information About the Harmful and Desirable Ingredients Found in Cosmetics and Cosmeceuticals By Ruth Winter
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27995746 | http://onlinelibrary.wiley.com/doi/10.1002/047084289X.rn01568/abstract?userIsAuthenticated=false&deniedAccessCustomisedMessage=https://www.ncbi.nlm.nih.gov/pubmed/27684194 | https://www.ncbi.nlm.nih.gov/pubmed/17511797 | https://www.ncbi.nlm.nih.gov/pubmed/1427505https://books.google.ru/books?id=3hLmyma2-MsC&pg=PA241&lpg=PA241&dq=FERRIC+AMMONIUM+CHLORIDE retrieved from A Consumer's Dictionary of Cosmetic Ingredients, 7th Edition: Complete Information About the Harmful and Desirable Ingredients Found in Cosmetics and Cosmeceuticals By Ruth Winter
Iron compound. Used as a styptic and astringent.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Additrace N Approved UseA source of electrolytes and trace elements as an integral part of a complete intravenous nutritional regimen, for adults and
children over 40 kg. |
|||
| Preventing | Parmirin Approved UsePreventive treatment of iron deficiency |
|||
| Palliative | VELPHORO Approved UseVelphoro is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. Launch Date2013 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| A Simplified Fe-Based PhotoATRP Using Only Monomers and Solvent. | 2017-07 |
|
| Effect of iron and carbon monoxide on fibrinogenase-like degradation of plasmatic coagulation by venoms of four Crotalus species. | 2017-01 |
|
| Ferric Chloride-induced Murine Thrombosis Models. | 2016-09-05 |
|
| Halide Influence on Molecular and Supramolecular Arrangements of Iron Complexes with a 3,5-Bis(2-Pyridyl)-1,2,4,6-Thiatriazine Ligand. | 2016-06-06 |
|
| Iron-Catalyzed Regioselective Transfer Hydrogenative Couplings of Unactivated Aldehydes with Simple Alkenes. | 2016-05-17 |
|
| Mechanisms and origins of the switchable regioselectivity of FeBr3-catalyzed [1,2]-aryl and [1,2]-alkyl shifts of α-aryl aldehydes. | 2016-02-28 |
|
| Nazarov cyclization of 1,4-pentadien-3-ols: preparation of cyclopenta[b]indoles and spiro[indene-1,4'-quinoline]s. | 2016-02-14 |
|
| Oxidative aromatic C-N bond formation: convenient synthesis of N-amino-3-nitrile-indoles via FeBr3-mediated intramolecular cyclization. | 2011-05-21 |
|
| Metal-mediated cyclization of aryl and benzyl glycidyl ethers: a complete scenario. | 2008-12-17 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27072872
Various alkyl aldehydes with linear alkyl chains were highly reactive under
these conditions and afforded the corresponding products in
good to excellent yields in the presence of 1 or 5 mol% of
FeBr3 (Ferric bromide).
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000175597
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m5322
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID3042057
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
PRIMARY | |||
|
Sucroferric oxyhydroxide
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
PRIMARY | |||
|
9793696
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
PRIMARY | |||
|
100000131810
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
PRIMARY | |||
|
DB14695
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
PRIMARY | |||
|
1484283
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
PRIMARY | RxNorm | ||
|
87PZU03K0K
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
PRIMARY | |||
|
20344-49-4
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
PRIMARY | |||
|
SUB46428
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
PRIMARY | |||
|
1310-14-1
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
NON-SPECIFIC STOICHIOMETRY | |||
|
243-746-4
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
PRIMARY | |||
|
87PZU03K0K
Created by
admin on Mon Mar 31 18:07:29 GMT 2025 , Edited by admin on Mon Mar 31 18:07:29 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD